Table 4 Clinical information of high risk PC patients with low or high MAOA expression after RP-PLND. (L: low expression; H: high expression)
From: High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients
MAOA-L | MAOA-H | P | MAOA-L | MAOA-H | P | |
|---|---|---|---|---|---|---|
cases (%) | cases (%) | cases (%) | cases (%) | |||
Age (years) | 53–73 | 52–71 | 0.60 | 53–73 | 52–71 | 0.51 |
(60.0 ± 13.0) | (60.5 ± 9.5) | (63.0 ± 10.0) | (62 ± 9) | |||
ECOG PS ≥ 1 | ||||||
No | 36(54.5%) | 64(66.0%) | 32(55.2%) | 34(58.6%) | ||
Yes | 30(45.5%) | 33(34.0%) | 0.19 | 26(44.8%) | 24(41.4%) | 0.85 |
Pathological stage | ||||||
< T2c | 20(30.3%) | 36(37.1%) | 20(34.5%) | 22(37.9%) | ||
≥ T2c | 46(69.7%) | 61(62.9%) | 0.40 | 38(65.5%) | 36(62.1%) | 0.85 |
PSA (ng/mL) | ||||||
≤ 20 | 29(43.9%) | 25(25.8%) | 21(36.2%) | 17(29.3%) | ||
> 20 | 37(56.1%) | 72(74.2%) | 0.018 | 37(63.8%) | 41(70.7%) | 0.55 |
GS | ||||||
< 8 | 23(34.8%) | 18(18.6%) | 18(31.0%) | 14(24.1%) | ||
≥ 8 | 43(65.2%) | 79(81.4%) | 0.027 | 40(69.0%) | 44(75.9%) | 0.53 |
pLN | ||||||
0 | 60(90.1%) | 75(77.3%) | 52(89.7%) | 49(84.5%) | ||
1 | 6(9.9%) | 22(22.7%) | 0.033 | 6(10.3%) | 9(15.5%) | 0.58 |